P881: CDK7 CONTRIBUTES TO METABOLIC REPROGRAMMING IN MM CELLS THROUGH C-MYC MEDIATED TRANSCRIPTIONAL CONTROL OF GLYCOLYTIC GENES

Autor: Y. Yao, J. Fong Ng, W. D. Park, D. Gramegna, A. Samur, M. Samur, E. Morelli, M. Chesi, C. Mitsiades, K. C. Anderson, C. Lin, N. Munshi, M. Fulciniti

Publikováno v: HemaSphere, Vol 6, Pp 773-774 (2022)

Externí odkaz: https://doaj.org/article/a6d608258cd94bae93cdc98af2a4b0be

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

Autor: C. Fernández de Larrea, R. A. Kyle, B. G. M. Durie, H. Ludwig, S. Usmani, D. H. Vesole, R. Hajek, J. F. San Miguel, O. Sezer, P. Sonneveld, S. K. Kumar, A. Mahindra, R. Comenzo, A. Palumbo, A. Mazumber, K. C. Anderson, P. G. Richardson, A. Z. Badros, J. Caers, X. LeLeu, M. A. Dimopoulos, C. S. Chim, R. Schots, A. Noeul, D. Fantl, U. H. Mellqvist, O. Landgren, A. Chanan Khan, P. Moreau, R. Fonseca, G. Merlini, J. J. Lahuerta, J. Bladé, R. Z. Orlowski, J. J. Shah, on behalf of the International Myeloma Working Group [, CAVO, MICHELE, ZAMAGNI, ELENA

Publikováno v: Leukemia, 27(4), 780-791. Nature Publishing Group
Fernández de Larrea, C, Kyle, R A, Durie, B G M, Ludwig, H, Usmani, S, Vesole, D H, Hajek, R, San Miguel, J F, Sezer, O, Sonneveld, P, Kumar, S K, Mahindra, A, Comenzo, R, Palumbo, A, Mazumber, A, Anderson, K C, Richardson, P G, Badros, A Z, Caers, J, Cavo, M, LeLeu, X, Dimopoulos, M A, Chim, C S, Schots, R, Noeul, A, Fantl, D, Mellqvist, U-H, Landgren, O, Chanan-Khan, A, Moreau, P, Fonseca, R, Merlini, G, Lahuerta, J J, Bladé, J, Orlowski, R Z, Shah, J J & International Myeloma Working Group 2013, ' Plasma cell leukemia : consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group ', Leukemia Insights, vol. 27, no. 4, pp. 780-91 . https://doi.org/10.1038/leu.2012.336
Digital.CSIC. Repositorio Institucional del CSIC
instname

PMCID: PMC4112539.-- International Myeloma Working Group: et al.
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified as either primary PCL occurring a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2429b40fe6c5638ae3ea1bcf0c185f9
https://doi.org/10.1038/leu.2012.336

Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies

Autor: Klaus Podar, K C Anderson

Publikováno v: Current Cancer Drug Targets. 11:1005-1024

Research on the formation of new blood vessels (angiogenesis) in general and vascular endothelial growth factor (VEGF) in particular is a major focus in biomedicine and has led to the clinical approval of the monoclonal anti- VEGF antibody bevazicuma

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70b384376ff77407c1810253e044c2d7
https://doi.org/10.2174/156800911798073113

Identification of tumor-associated antigens differentially expressed between Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Autor: S. Blotta, P. Tassone, P. Tagliaferri, S. Amin, D. Cervi, Y. T. Tai, K. Podar, C. S. Mitsiades, J. Jakubikova, A. Zullo, S. Venuta, N. C. Munshi, K. C. Anderson, FRANCO, BRUNELLA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3730::a82e6be5b0de326044d668d612b87708
http://hdl.handle.net/11588/358442

CD20-Directed Antibody-Mediated Immunotherapy Induces Responses and Facilitates Hematologic Recovery in Patients With Waldenstrom’s Macroglobulinemia

Autor: Bruce Clark, Brian A. Link, Arturo Molina, Arthur I. Richards, Martha Q. Lacy, K. C. Anderson, Steven P. Treon, David P. Schenkein, Robert Schlossman, Marjorie S. Lucas, Eva Kimby, David C. Fisher, David B. Agus, John C. Byrd, Christos Emmanouilides, Boris Lin, Gilberto Rodrigues

Publikováno v: Karolinska Institutet

Waldenstrom's macroglobulinemia (WM, lymphoplasmacytic lymphoma) is a B-cell lymphoproliferative disorder in which CD20 is expressed on tumor cells from most patients. Several small studies have suggested a benefit from the anti-CD20 monoclonal antib

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c66a5ef276ab8474906a3d6beacc617f
https://doi.org/10.1097/00002371-200105000-00012